In a 70-year-old woman with hyperostosis frontalis interna (HFI) presenting with new-onset headache, how frequently is HFI associated with meningioma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Hyperostosis Frontalis Interna and Meningioma Association

Hyperostosis frontalis interna (HFI) is NOT directly associated with meningioma, and the presence of HFI in a 70-year-old woman with new-onset headaches should not raise specific concern for meningioma beyond baseline risk for her age and sex.

Key Distinction: HFI vs. Meningioma-Associated Hyperostosis

The critical point is understanding that these are two entirely different entities with different mechanisms:

HFI Characteristics:

  • Benign bone thickening affecting the inner table of the frontal bone 1, 2
  • Predominantly affects postmenopausal women 1, 3
  • Involves only the inner table, sparing the diploe and outer table 2
  • Likely related to hormonal factors 1
  • Considered a benign incidental finding 1

Meningioma-Associated Hyperostosis:

  • Represents bony invasion by tumor 4
  • Occurs particularly in skull base meningiomas 4
  • Associated with a dural-based mass lesion 4
  • Shows characteristic imaging features including the "dural tail sign" and contrast enhancement 4

Clinical Approach to New-Onset Headaches in This Patient

The new-onset headache warrants investigation, but not because of the HFI itself. Here's the algorithmic approach:

Risk Stratification:

  1. Age 70 years = increased baseline risk for meningioma (most common primary CNS tumor from age 35 onward) 5
  2. Female sex = 3:2 increased risk for meningioma compared to males 4
  3. New-onset headache in older patient = concerning feature per headache guidelines 6

Imaging Recommendation:

  • MRI brain with and without contrast is indicated 4, 7
  • This is based on the new-onset headache in an older patient, NOT because of the HFI
  • MRI is superior to CT for detecting meningiomas and evaluating dural-based lesions 4

What to Look For on Imaging:

If meningioma is present, expect:

  • Dural-based mass with cortical buckling 4
  • Strong uniform contrast enhancement 4
  • Possible "dural tail sign" 4
  • Hyperostosis may be present but would be localized to the tumor site, not diffuse frontal involvement like HFI 4

Common Pitfall to Avoid

Do not confuse diffuse HFI with focal meningioma-associated hyperostosis. The differential diagnosis of cranial hyperostosis includes meningioma, osteoma, Paget's disease, and fibrous dysplasia 2, but:

  • HFI shows bilateral, symmetric frontal bone thickening 3, 8
  • Meningioma-associated hyperostosis is focal and associated with a soft tissue mass 4
  • Recent MRI studies show HFI can demonstrate variable enhancement patterns (31% show some enhancement) 8, which could potentially cause confusion, but the distribution pattern and absence of associated mass distinguish it from meningioma

Clinical Manifestations of HFI

While investigating the headache, note that HFI itself has been associated with various symptoms in case reports 9:

  • Headaches (>20% frequency) 9
  • Obesity, vertigo/dizziness, cognitive decline, depression 9

However, these associations are from case reports and do not establish causation. The headache should be evaluated on its own merits as a new symptom in an older patient.

Bottom Line

The frequency of HFI-meningioma association is essentially zero—they are unrelated conditions. The patient's imaging workup should proceed based on standard criteria for new-onset headache in an older woman, where her age and sex already place her at higher baseline risk for meningioma 5. The presence of HFI is an incidental finding that should not influence clinical decision-making regarding meningioma risk 1, 2.

Related Questions

In a 70-year-old woman with hyperostosis frontalis interna who presents with a new-onset headache and a non-contrast CT showing a midline shift or a pathological extra-axial fluid collection, what are the differential diagnoses?
In a patient with hyperostosis over the thymus, is there any relationship to hyperostosis of the sagittal suture?
What is a hyperostosis presenting as a raised bony exostosis on the vertex of the skull along the suture line, extending posteriorly about 3 inches?
Can sustained pressure from hyperostosis along the sagittal suture cause localized hair thinning?
How common is hyperostosis frontalis interna (HFI) in 70-year-old women?
Is hormone replacement therapy (estrogen) safe for a patient using a Mirena (levonorgestrel) intrauterine device, and does the IUD eliminate the need for a systemic progestin?
Why do women of reproductive age experience increased libido during the mid‑cycle (ovulatory phase) but not earlier in the menstrual cycle?
In a 66‑year‑old patient with a prosthetic heart valve and paroxysmal atrial fibrillation who is taking simvastatin, nitrazepam 5 mg daily, furosemide, bisoprolol, valsartan, moxonidine, and spironolactone, what precautions should be taken when prescribing psychotropic medications?
How should low prothrombin time, activated partial thromboplastin time, and international normalized ratio be evaluated and managed?
What are the recommended dosing regimens, administration guidelines, contraindications, and common adverse effects of semaglutide for adults with type 2 diabetes or obesity?
In a patient with worsening renal function, stage IV chronic kidney disease, ascites, oliguria, and hyperkalemia (serum potassium >5 mmol/L), what is the appropriate management?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.